Ebola
... treatment has been proven effective, and no
vaccine currently exists. A
vaccine is in the developmental stages. Ebola is known ... on humans except in outbreak environments so the
vaccine must be tested extensively and meet strict ...
Louis Pasteur
... of inoculation , most notably the first
vaccine against rabies ; however, he also made a major ... Jenner's discovery. Pasteur produced the first
vaccine for rabies by growing the virus in rabbits and ... it by drying the affected nerve tissue. This
vaccine was first used on 9-year old Joseph Meister on ...
Malaria
... under development, with no completely effective
vaccine yet available (as of November 2004 ). A team ... trial in October 2004 , for RTS,S/AS02A , a
vaccine which reduces infection risk by 30% and severity ... [1] . Further necessary research will delay this
vaccine from commercial release until around 2010 . In ...
Vaccine
... A
vaccine is an antigenic preparation used to produce ... side effects in general
4 Economics of
vaccine development
5 See also
6 External links ... and diphtheria
The live tuberculosis
vaccine is not the contagious TB strain, but a related ...
Edward Jenner
... , England , famous for his work introducing the Smallpox
vaccine .
Jenner's early education included a spell at Cirencester Grammar ... elected a Fellow of the Royal Society in 1789.
Related topics
vaccine
Vaccination
External links
Jenner's papers on ...
Hepatitis B
... B virus (Hepatitis B immune globulin or HBIG). When given with the
vaccine within twelve hours of birth, the risk of acquiring Hepatitis B is reduced ... must be soon after exposure, however.
Prevention
A recombinant
vaccine is available to prevent hepatitis B.
Many countries now routinely ...
Yellow fever
... African and South American countries despite existence of an effective
vaccine . In the past it was a source of several devastating epidemics.
The ... 3 History
4 References
5 Other meanings
Prevention
A
vaccine for yellow fever was developed which gives a 10-year+ immunity from the ...
Antibiotic resistance
... not hoard pills for later use or share leftover antibiotics.
Vaccines
Vaccines do not suffer the problem of resistance. This is because a
vaccine enhances the body's natural defenses, while an antibiotic operates separately from the body's normal defenses. Nevertheless, new strains may evolve ...
Antibiotic resistance
... not hoard pills for later use or share leftover antibiotics.
Vaccines
Vaccines do not suffer the problem of resistance. This is because a
vaccine enhances the body's natural defenses, while an antibiotic operates separately from the body's normal defenses. Nevertheless, new strains may evolve ...
Retrovirus
... very often. This enables the virus to grow resistant to antiviral pharmaceuticals quickly, and is one of the main reasons why an effective
vaccine for HIV has not been developed yet.
Among others, retrovirus genomes commonly contain three genes , that encode proteins that can be found back ...
Varicella zoster virus
... of drugs and therapeutic agents including aciclovir , zoster immunoglobulin (ZIG), and vidarabine .
A live attenuated VZV Oka/Merck strain
vaccine is available and is marketed under the trade name Varivax . It was developed by Merck, Sharp & Dohme in the 1980s from the Oka strain virus ...